This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2017 May 2;317(17):1772-1773.

doi: 10.1001/jama.2017.4455.

Reconsidering Physician-Pharmaceutical Industry Relationships

Colette DeJong¹, R Adams Dudley²

Affiliations

Affiliations

¹ Center for Healthcare Value, Philip R. Lee Institute for Health Policy Studies, School of Medicine, University of California, San Francisco.
² Center for Healthcare Value, Philip R. Lee Institute for Health Policy Studies, School of Medicine, University of California, San Francisco2Department of Medicine, School of Medicine, University of California, San Francisco.

PMID: 28464124
DOI: 10.1001/jama.2017.4455

Editorial

Reconsidering Physician-Pharmaceutical Industry Relationships

Colette DeJong et al. JAMA. 2017.

. 2017 May 2;317(17):1772-1773.

doi: 10.1001/jama.2017.4455.

Authors

Colette DeJong¹, R Adams Dudley²

Affiliations

¹ Center for Healthcare Value, Philip R. Lee Institute for Health Policy Studies, School of Medicine, University of California, San Francisco.
² Center for Healthcare Value, Philip R. Lee Institute for Health Policy Studies, School of Medicine, University of California, San Francisco2Department of Medicine, School of Medicine, University of California, San Francisco.

PMID: 28464124
DOI: 10.1001/jama.2017.4455

No abstract available

PubMed Disclaimer

Comment on

Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing.
Larkin I, Ang D, Steinhart J, Chao M, Patterson M, Sah S, Wu T, Schoenbaum M, Hutchins D, Brennan T, Loewenstein G. Larkin I, et al. JAMA. 2017 May 2;317(17):1785-1795. doi: 10.1001/jama.2017.4039. JAMA. 2017. PMID: 28464141 Free PMC article.

Similar articles

Conflict of interest in the physician interface with the biomedical industry.
Minnigan H, Chisholm CD. Minnigan H, et al. Emerg Med Clin North Am. 2006 Aug;24(3):671-85. doi: 10.1016/j.emc.2006.05.008. Emerg Med Clin North Am. 2006. PMID: 16877136 Review.
The ethics of physician-pharmaceutical company relationships.
Thompson WG. Thompson WG. CMAJ. 1988 Nov 1;139(9):835-6. CMAJ. 1988. PMID: 3179887 Free PMC article. No abstract available.
Snake oil and Caesar salad: the ethics of physician and pharmaceutical relationships.
Woollard RF. Woollard RF. CMAJ. 1991 Oct 15;145(8):931-3. CMAJ. 1991. PMID: 1913426 Free PMC article. No abstract available.
Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics.
Solomon AJ, Klein EP, Corboy JR, Bernat JL. Solomon AJ, et al. Mult Scler. 2015 Oct;21(12):1593-9. doi: 10.1177/1352458515569101. Epub 2015 Feb 25. Mult Scler. 2015. PMID: 25716879
Letting the sunshine in: shining a new light on physician-industry relationships.
Bruguera CM, Hirsch JA. Bruguera CM, et al. J Neurointerv Surg. 2010 Mar;2(1):80-2. doi: 10.1136/jnis.2010.002196. J Neurointerv Surg. 2010. PMID: 21990565 Review.

See all similar articles

Cited by

Industry Payments to Orthopedic Surgeons Among All Subspecialties: An Analysis of the Open Payments Database From 2014 to 2019.
Tarazi JM, Frane N, Sherman AE, White PB, Partan M, Humphrey EK, Bitterman A. Tarazi JM, et al. Cureus. 2024 Feb 26;16(2):e54981. doi: 10.7759/cureus.54981. eCollection 2024 Feb. Cureus. 2024. PMID: 38550480 Free PMC article.
Undisclosed financial conflicts of interest in DSM-5-TR: cross sectional analysis.
Davis LC, Diianni AT, Drumheller SR, Elansary NN, D'Ambrozio GN, Herrawi F, Piper BJ, Cosgrove L. Davis LC, et al. BMJ. 2024 Jan 10;384:e076902. doi: 10.1136/bmj-2023-076902. BMJ. 2024. PMID: 38199616 Free PMC article.
Open data on industry payments to healthcare providers reveal potential hidden costs to the public.
Mejia J, Mejia A, Pestilli F. Mejia J, et al. Nat Commun. 2019 Sep 20;10(1):4314. doi: 10.1038/s41467-019-12317-z. Nat Commun. 2019. PMID: 31541096 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations